Free Trial
OTCMKTS:SDMHF

Sartorius Stedim Biotech (SDMHF) Stock Price, News & Analysis

Sartorius Stedim Biotech logo
$218.00 0.00 (0.00%)
As of 02/21/2025

About Sartorius Stedim Biotech Stock (OTCMKTS:SDMHF)

Key Stats

Today's Range
$218.00
$218.00
50-Day Range
$195.00
$236.50
52-Week Range
$158.00
$299.86
Volume
20,000 shs
Average Volume
1,478 shs
Market Capitalization
N/A
P/E Ratio
50.58
Dividend Yield
0.55%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

Receive SDMHF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter.

SDMHF Stock News Headlines

Why 2026 will be a disaster for many Americans
Wall Street Legend: Why stocks are very likely to crash in Trump's 2nd Year Legendary investor Marc Chaikin says stocks could crash in 2026—he's even calling the exact month and most likely day it will start. No one on or off Wall Street has been more accurate calling the bull and bear turns of the past 7 years. And now, Chaikin is calling the crash of 2026.
Sartorius Stedim Biotech (0RG8) Receives a Buy from Jefferies
Goldman Sachs Keeps Their Buy Rating on Sartorius Stedim Biotech (0RG8)
Sartorius Stedim Biotech (0RG8) Gets a Buy from RBC Capital
See More Headlines

SDMHF Stock Analysis - Frequently Asked Questions

Sartorius Stedim Biotech's stock was trading at $195.00 at the beginning of the year. Since then, SDMHF stock has increased by 11.8% and is now trading at $218.00.
View the best growth stocks for 2025 here
.

Shares of SDMHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
2/24/2025
Next Earnings (Estimated)
4/16/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:SDMHF
CIK
N/A
Fax
N/A
Employees
10,382
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (OTCMKTS:SDMHF) was last updated on 2/24/2025 by MarketBeat.com Staff
From Our Partners